Skip to content

The John van Geest Cancer Research Centre

The John van Geest Cancer Research Centre is a unique, purpose-built scientific facility in the East Midlands focusing on cancer research into diagnosis, prognosis, and treatment.

The Centre has a strong research base that investigates disease processes with regards to cancer’s molecular heterogeneity, the architecture of the tumour microenvironment and the identification of biomarkers associated with therapeutic success and failure.​

The Centre aligns with the Health and Wellbeing strategic theme at NTU and the Centre for Health, Ageing and Understanding Disease, and sits in the School of Science and Technology.

Our mission

A diagram of three points following an upwards arrow, from the lab to a DNA helix, to a stethoscope.

We work globally to ensure that benefit is delivered to patients with cancer and to the broader society.

Our vision is to work collaboratively to improve health and wellbeing through fundamental and translational research into the molecular basis of cancer heterogeneity and tumour-host interactions. We are keen to understand how these pathways can be targeted to yield better outcomes for many patients with cancer (personalised oncology), while also avoiding toxicities in individuals who are unlikely to respond to conventional, non-individualised anti-cancer treatments.

To address challenges and unmet clinical needs in the cancer field, we are implementing and testing transformative therapeutic approaches, including antibody-based treatments and anti-tumour vaccination, that are tailored to specific, molecularly-defined patient subgroups.

We aim to save lives and speed recovery by improving the early diagnosis and treatment of cancer. Our mission is to turn biomedical discovery into health and benefit for patients via the following roadmap:

  1. Computationally and technology fuelled investigation of the molecular heterogeneity of cancer
  2. Identification of patient-specific cancer cell vulnerabilities and actionable targets
  3. Translation into clinical benefit (precision oncology)

Researchers and facilities

The Centre Director is NTU Professor of Cancer and Immunotherapy Sergio Rutella. Our research at the John van Geest Cancer Research Centre wouldn't be possible without a collaboration with NTU's academics and facilities, as well as local, national, and global communities dedicated to making a real difference in cancer research.


We collaborate with academics and commercial partners across the UK, Europe and USA, as well as with other departments at NTU (Biosciences, Psychology, Sports Science). ​

In addition to our local collaborations, we also have active collaborations in countries world-wide including Germany, Norway and the USA.​ Some examples include:​

  • Division of Oncology, Children’s Hospital of Philadelphia, USA​
  • Department of Internal Medicine II and Institute of Immunology, University of Dresden, Germany​
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA​
  • MacroGenics Inc, Rockville, USA​
  • NanoString Technologies Inc, Seattle, USA​
  • Kura Oncology, San Diego, USA​
  • Scancell Ltd, Nottingham​
  • Ultimovacs AS, Norway​
  • UCB Pharma, UK​
  • Intelligent OMICS, UK


The John van Geest Cancer Research Centre has a comprehensive research infrastructure and is equipped with the following platform technologies:​

  • NanoString nCounter XT​
  • NanoString GeoMx Digital Spatial Profiler​
  • MoFlo XDP Cell Sorter​
  • Gallios Flow Cytometer​
  • Gel Doc- Syngene Gbox Imager​
  • PALM Microbeam Laser Capture Microdissector​
  • 2 x Sciex Triple TOF instruments utilizing SWATH for quantitation​
  • Bruker UltrafleXtreme MALDI-TOF​
  • Bio-Plex Multiplex Immunoassay System​
  • xCelligence RTCA DP real-time cell analyser
  • Cytek Aurora Spectral Flow Cytometer

How you can help

Our work is entirely dependant on the generous donations from our alumni and supporters. Here's how you can help us improve the lives of those affected by cancer.

Follow us!